We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-0.88%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$33.9B
AUM Growth
-$12.9B
Cap. Flow
-$11.3B
Cap. Flow %
-33.44%
Top 10 Hldgs %
7.18%
Holding
4,846
New
656
Increased
881
Reduced
976
Closed
2,304

Top Buys

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$226M
2
JPM icon
JPMorgan Chase
JPM
+$212M
3
TSM icon
TSMC
TSM
+$204M
4
OXY icon
Occidental Petroleum
OXY
+$194M
5
AAPL icon
Apple
AAPL
+$180M

Sector Composition

Rank Sector Weight
1 Technology 18.48%
2 Healthcare 15.21%
3 Industrials 10.23%
4 Consumer Discretionary 10.15%
5 Financials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIGO icon
2301
Millicom
TIGO
$16B
$219K ﹤0.01%
+8,696
New +$224K
DJCO icon
2302
Daily Journal
DJCO
$855M
$217K ﹤0.01%
697
HOFV
2303
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$217K ﹤0.01%
+8,896
New +$229K
TCON
2304
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$217K ﹤0.01%
4,125
-5,895
-59% -$296K
URI icon
2305
United Rentals
URI
$66.5B
$215K ﹤0.01%
+606
New +$198K
MRNS
2306
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$214K ﹤0.01%
+22,916
New +$228K
NVNO
2307
enVVeno Medical
NVNO
$7.92M
$213K ﹤0.01%
953
-970
-50% -$188K
PLG
2308
Platinum Group Metals
PLG
$198M
$210K ﹤0.01%
99,720
+1,659
+2% +$3.21K
LIVE icon
2309
Live Ventures
LIVE
$29.3M
$209K ﹤0.01%
+4,767
New +$155K
SAGE
2310
DELISTED
Sage Therapeutics
SAGE
$209K ﹤0.01%
+6,319
New +$238K
MXCT icon
2311
MaxCyte
MXCT
$137M
$208K ﹤0.01%
29,703
+7,408
+33% +$50.6K
EDVA
2312
Endovia Health Sciences, Inc.
EDVA
$2.66M
$208K ﹤0.01%
+458
New +$234K
TBI
2313
Trueblue
TBI
$320M
$205K ﹤0.01%
+7,103
New +$195K
PRVA icon
2314
Privia Health
PRVA
$2.74B
$203K ﹤0.01%
7,600
-23,000
-75% -$543K
TMP icon
2315
Tompkins Financial
TMP
$1.41B
$203K ﹤0.01%
2,597
-5,343
-67% -$431K
POLY
2316
DELISTED
Plantronics, Inc.
POLY
$203K ﹤0.01%
5,160
-11,881
-70% -$338K
SGHC icon
2317
SGHC Ltd
SGHC
$6.96B
$200K ﹤0.01%
+18,693
New +$162K
SHIP icon
2318
Seanergy Maritime Holdings
SHIP
$386M
$200K ﹤0.01%
+17,532
New +$190K
NEXN
2319
Nexxen International
NEXN
$562M
$199K ﹤0.01%
13,055
+1,068
+9% +$15.4K
BFX
2320
DELISTED
BowFlex Inc.
BFX
$199K ﹤0.01%
48,187
-173,083
-78% -$861K
SCOR icon
2321
Comscore
SCOR
$78.5M
$197K ﹤0.01%
3,385
-9,843
-74% -$564K
CORZ
2322
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$197K ﹤0.01%
+23,897
New +$211K
AATC
2323
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
$197K ﹤0.01%
30,871
-19,925
-39% -$132K
AIFA
2324
All In FutureTech Alliance Inc
AIFA
$19.8M
$194K ﹤0.01%
18,738
+955
+5% +$10.3K
CTRE icon
2325
CareTrust REIT
CTRE
$9.47B
$194K ﹤0.01%
10,046
-21,311
-68% -$420K

Similar funds

John Overdeck's Q1 2022 Portfolio in Review

As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, John Overdeck opened a new position in Cisco worth $223M.

  • John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
  • John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
  • John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
  • John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
  • John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
  • John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
  • John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.